IN2009KN04355A - - Google Patents
Download PDFInfo
- Publication number
- IN2009KN04355A IN2009KN04355A IN4355KON2009A IN2009KN04355A IN 2009KN04355 A IN2009KN04355 A IN 2009KN04355A IN 4355KON2009 A IN4355KON2009 A IN 4355KON2009A IN 2009KN04355 A IN2009KN04355 A IN 2009KN04355A
- Authority
- IN
- India
- Prior art keywords
- promoter
- poll
- useful
- rna polymerase
- rna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94665107P | 2007-06-27 | 2007-06-27 | |
| EP07450177A EP2045323A1 (fr) | 2007-10-05 | 2007-10-05 | Constructions linéaires d'expression pour la production de particules de virus influenza |
| PCT/EP2008/058182 WO2009000891A2 (fr) | 2007-06-27 | 2008-06-26 | Nouvelles constructions de l'expression du virus de la grippe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009KN04355A true IN2009KN04355A (fr) | 2015-07-10 |
Family
ID=39099653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4355KON2009 IN2009KN04355A (fr) | 2007-06-27 | 2008-06-26 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100129399A1 (fr) |
| EP (2) | EP2045323A1 (fr) |
| CN (1) | CN101952427A (fr) |
| AU (1) | AU2008267180B2 (fr) |
| CA (1) | CA2689569C (fr) |
| EA (1) | EA017456B1 (fr) |
| IN (1) | IN2009KN04355A (fr) |
| NZ (1) | NZ582102A (fr) |
| WO (1) | WO2009000891A2 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9091510B2 (en) | 2007-03-21 | 2015-07-28 | Schott Corporation | Transparent armor system and method of manufacture |
| EP2072058A1 (fr) | 2007-12-21 | 2009-06-24 | Avir Green Hills Biotechnology Research Development Trade Ag | Virus de la grippe modifié |
| EP2233568A1 (fr) * | 2009-03-19 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade AG | Nouveau procédé pour la génération de virus d'ARN |
| JP5836266B2 (ja) | 2009-05-21 | 2015-12-24 | ノバルティス アーゲー | 非内因性ｐｏｌＩプロモーターを使用した逆遺伝学 |
| CN102666860B (zh) * | 2009-07-31 | 2015-06-17 | 诺华股份有限公司 | 反向遗传系统 |
| AU2010309404B2 (en) | 2009-10-20 | 2015-07-09 | Seqirus UK Limited | Improved reverse genetics methods for virus rescue |
| KR20130115105A (ko) * | 2010-06-02 | 2013-10-21 | 박스터 헬쓰케어 에스에이 | Rna 바이러스를 생산하는 방법 및 헬퍼 바이러스 |
| CN102495208B (zh) * | 2011-10-24 | 2014-03-26 | 山东省农业科学院畜牧兽医研究所 | 禽流感病毒rt-pcr elisa试剂盒 |
| WO2013067652A1 (fr) * | 2011-11-10 | 2013-05-16 | Beijing Advaccine Biotechnology Co., Ltd. | Vaccin à combinaison facilitateur-adn |
| CA2813723A1 (fr) | 2012-03-02 | 2013-09-02 | Novartis Ag | Sent to trans |
| MX2015006927A (es) | 2012-12-03 | 2016-02-05 | Novartis Ag | Redistribucion de virus de la influenza. |
| JP6525469B2 (ja) | 2013-03-13 | 2019-06-05 | ノバルティス アーゲー | インフルエンザｂ型ウイルス再集合 |
| DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
| DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
| CA2914604A1 (fr) | 2013-06-06 | 2014-12-11 | Novartis Ag | Reassortiment du virus de la grippe |
| WO2016207853A2 (fr) | 2015-06-26 | 2016-12-29 | Seqirus UK Limited | Vaccins contre la grippe à correspondance antigénique |
| JP6830070B2 (ja) | 2015-07-07 | 2021-02-17 | セキラス ユーケー リミテッドＳｅｑｉｒｕｓ ＵＫ Ｌｉｍｉｔｅｄ | インフルエンザ効力アッセイ |
| KR20220128613A (ko) | 2019-11-18 | 2022-09-21 | 세퀴러스 피티와이 리미티드 | 재배열 인플루엔자 바이러스의 제조 방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE384126T1 (de) * | 1998-06-12 | 2008-02-15 | Sinai School Medicine | Interferon induzierende genetisch veränderte attenuierte viren |
| KR20060080249A (ko) * | 1998-06-12 | 2006-07-07 | 마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 | 변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스 |
| JP2002539800A (ja) * | 1999-03-24 | 2002-11-26 | ジーン セラピー システムズ インコーポレーテッド | 転写活性のあるｄｎａ断片を製造する方法 |
| ES2373405T3 (es) * | 1999-04-06 | 2012-02-03 | Wisconsin Alumni Research Foundation | Virus de la gripe recombinantes para vacunas y terapia génica. |
| DE122008000056I1 (de) * | 1999-07-14 | 2009-04-09 | Sinai School Medicine | In vitro-rekonstitution von segmentierten negativstrang-rna-viren |
| UA84254C2 (ru) * | 2000-04-28 | 2008-10-10 | Ст. Джуд Чилдренз Ресерч Хоспитал | МИНИМАЛЬНАЯ ПЛАЗМИДНАЯ СИСТЕМА ДЛЯ ГЕНЕРИРОВАНИЯ ИНФЕКЦИОННЫХ МИНУС-ЦЕПОЧЕЧНЫХ РНК ВИРУСОВ С КЛОНИРОВАННОЙ ВИРУСНОЙ кДНК, КЛЕТКА-ХОЗЯИН, КОТОРАЯ ВКЛЮЧАЕТ ПЛАЗМИДНУЮ СИСТЕМУ, СПОСОБ ПРОДУЦИРОВАНИЯ ИНФЕКЦИОННОГО МИНУС-ЦЕПОЧЕЧНОГО РНК ВИРУСА И СПОСОБ ПРИВИВКИ СУБЪЕКТА ОТ ИНФЕКЦИИ МИНУС-ЦЕПОЧЕЧНОГО РНК ВИРУСА |
| ES2526191T3 (es) * | 2002-04-26 | 2015-01-08 | Medimmune, Llc | Método para producir virus influenza B infeccioso en cultivo celular |
| JP4771959B2 (ja) * | 2003-12-23 | 2011-09-14 | メディミューン，エルエルシー | インフルエンザウイルス作製のための多重プラスミド系 |
| CA2610632C (fr) * | 2004-06-01 | 2022-10-04 | Mount Sinai School Of Medicine Of New York University | Virus de la grippe porcine genetiquement modifie et ses applications |
| EP1814990A2 (fr) * | 2004-11-19 | 2007-08-08 | Wisconsin Alumni Research Foundation | Vecteurs recombinants de la grippe avec des unites de transcription en tandem |
| US8043856B2 (en) * | 2007-06-14 | 2011-10-25 | Wisconsin Alumni Research Foundation | Adenoviral vectors for influenza virus production |
-
2007
- 2007-10-05 EP EP07450177A patent/EP2045323A1/fr not_active Withdrawn
-
2008
- 2008-06-26 CA CA2689569A patent/CA2689569C/fr active Active
- 2008-06-26 IN IN4355KON2009 patent/IN2009KN04355A/en unknown
- 2008-06-26 CN CN2008800223549A patent/CN101952427A/zh active Pending
- 2008-06-26 AU AU2008267180A patent/AU2008267180B2/en active Active
- 2008-06-26 US US12/666,459 patent/US20100129399A1/en not_active Abandoned
- 2008-06-26 EP EP08774359.7A patent/EP2160462B1/fr active Active
- 2008-06-26 NZ NZ582102A patent/NZ582102A/en not_active IP Right Cessation
- 2008-06-26 WO PCT/EP2008/058182 patent/WO2009000891A2/fr active Application Filing
- 2008-06-26 EA EA201000076A patent/EA017456B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2160462A2 (fr) | 2010-03-10 |
| EA017456B1 (ru) | 2012-12-28 |
| CA2689569C (fr) | 2020-10-27 |
| AU2008267180A1 (en) | 2008-12-31 |
| WO2009000891A3 (fr) | 2009-02-26 |
| WO2009000891A2 (fr) | 2008-12-31 |
| CA2689569A1 (fr) | 2008-12-31 |
| EA201000076A1 (ru) | 2010-06-30 |
| EP2045323A1 (fr) | 2009-04-08 |
| AU2008267180B2 (en) | 2014-07-10 |
| US20100129399A1 (en) | 2010-05-27 |
| EP2160462B1 (fr) | 2017-07-26 |
| NZ582102A (en) | 2012-06-29 |
| CN101952427A (zh) | 2011-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009KN04355A (fr) | ||
| EA200501890A1 (ru) | Вирусы гриппа высокого титра для приготовления вакцин и генной терапии | |
| WO2009143524A3 (fr) | Vaccins à nanoémulsion | |
| WO2017070620A3 (fr) | Vaccin contre le virus de la grippe à large spectre | |
| MXPA06013411A (es) | Procedimiento para la produccion de una vacuna contra la influenza. | |
| WO2008011636A3 (fr) | Administration de gène ciblée pour une vaccination des cellules dendritiques | |
| EP3492597A3 (fr) | Compositions de vecteur aav3 recombinant à capside modifiée et procédés d'utilisation dans la thérapie génétique du cancer du foie chez l'homme | |
| MX2018008135A (es) | Moleculas de acido nucleico de influenza y vacunas elaboradas a partir de las mismas. | |
| MX2007007889A (es) | Rescate del virus de influenza. | |
| WO2022221335A8 (fr) | Vaccins associés contre des virus respiratoires | |
| WO2007053696A3 (fr) | Inhibition de la replication du virus de la grippe par interference arn | |
| WO2010021681A3 (fr) | Compositions et procédés pour le traitement de maladies virales | |
| MX342933B (es) | Acido nucleico que comprende o codifica para una secuencia de tallo-asa de histona y poli (a) o una señal de poliadenilacion para incrementar la expresion de una proteina codificada. | |
| AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
| PH12016500492A1 (en) | Pyridazinone compounds and uses thereof | |
| NZ606087A (en) | Influenza vaccine | |
| GB2386072A (en) | Novel vaccine | |
| EA201001045A1 (ru) | Модифицированный вирус гриппа | |
| EA201171370A1 (ru) | Универсальные способы определения вирусов гриппа | |
| EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
| NZ739260A (en) | Inactivated canine influenza vaccines and methods of making and uses thereof | |
| EP4126032A4 (fr) | Vaccin universel contre la grippe faisant appel à un arnm modifié par un nucléoside | |
| HUP0400479A2 (hu) | Parapoxvirus ovis törzsek alkalmazása vírusellenes és rákellenes gyógyszerek előállítására | |
| MX343948B (es) | Compuestos de peroxido organico para inactivacion de microorganismos. | |
| AU2016204276A1 (en) | Methods for producing virus particles with simplified glycosylation of surface proteins |